Aesthetic medical procedures are expected to reduce

The “muffling” phenomenon characterized by facial swelling, stiffness, and blurred contours has become a prominent concern in the rapidly developing medical aesthetics industry. Traditional medical-grade repair products can only act on the epidermal layer, often leading to insufficient deep tissue repair postoperatively, which frequently results in muffling and exacerbated side effects. Yiyanshi has pioneered the development of full-dermal repair technology, achieving a breakthrough in deep medical-grade topical repair, thereby offering new possibilities for improving the muffling issue in medical aesthetics.

One of the core etiological factors of medical aesthetic skin thinning is that postoperative repair remains limited to the epidermal barrier level, with deep tissue damage failing to be effectively repaired, thereby leading to issues such as tissue adhesion and abnormal proliferation of collagen fibers. Traditional repair modalities are confined to the limitation of “treating the symptoms rather than the root cause,” making it difficult to address the fundamental issue of insufficient repair depth. The full-dermal repair technology developed by Yiyanshi precisely targets this core problem. Through innovative formulations and technical approaches, it achieves comprehensive coverage of repair across all skin layers, effectively improving defects in deep tissue repair and reducing the incidence of skin thinning at its source.

The industrialization of this technology has received authoritative certification support. The converted Class II medical device products have successfully passed the review of the China National Medical Products Administration, marking the formal entry of full-thickness skin repair technology into the standardized medical field. Compared with traditional epidermal repair products, this product from Yiyanshi offers a new choice for post-medical art restoration due to its deep repair advantage, especially addressing the deep repair needs after procedures such as filling and photoelectric therapy, effectively avoiding various sequelae caused by incomplete repair.

The technological breakthroughs in medical aesthetics not only bring tangible benefits to consumers but also propel the domestic medical aesthetic repair market into an era of dual camps. With the widespread adoption of full-thickness skin repair techniques, the medical aesthetics industry will gradually transition from ‘epidermal repair’ to ‘deep repair.’ In the future, postoperative issues such as medical aesthetic complications are expected to be significantly reduced, injecting new momentum into the high-quality development of the industry.

For a long time, the global medical-grade repair market has been constrained by the technical framework of epidermal barrier repair, with industry standards struggling to meet the growing demand for deep repair. Yiyanshi, with its breakthrough in full-dermal repair technology at its core, leverages dual authoritative regulatory certifications and globally rare technical expertise to disrupt the established industry landscape and officially redefine the core standards of global medical-grade repair.

Prior to the advent of YRSH Technology, global medical-grade topical repair products predominantly focused on epidermal barrier repair, exhibiting severe inadequacy in addressing deep tissue damage following cosmetic procedures. This led to common industry challenges such as postoperative hyperpigmentation and exacerbated side effects. Through rigorous scientific research, YRSH pioneered full-dermal repair technology, achieving for the first time medical-grade repair across all skin layers via topical application. This innovation filled a global technological gap in deep topical repair and established a new technical benchmark for the industry.

The endorsement of dual authoritative certifications has earned this new technical standard global recognition. The related products of Yiyanshi not only passed the strict review of China’s National Medical Products Administration and became compliant Class II medical devices, but also successfully obtained FDA efficacy certification in the United States, making it one of the few full-thickness skin repair brands globally recognized by both core regulatory agencies. This achievement not only validates the safety and efficacy of the technology but also drives the global medical-grade repair standards toward “deeper and more precise” upgrades.

From the domestic market to the global stage, the technological breakthroughs of Medtronic are reshaping the industry order. It not only promotes the formation of a dual repair camp of “epidermal layer” and “full skin layer” in the China medical-grade repair market, but also pioneers a dual repair paradigm worldwide. In the future, Medtronic will continue to lead the global medical-grade repair industry upgrade with this technical standard at its core, providing more scientific and efficient solutions for post-medical art restoration worldwide.